Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised SEB in connection with the issuance of Additional Tier 1 Capital of USD 500 million
Mandate

Vinge has advised SEB in connection with the issuance of Additional Tier 1 Capital of USD 500 million

June 07, 2022 Banking and Finance Capital Markets and Public M&A

Vinge has advised Skandinaviska Enskilda Banken AB (publ) as to Swedish law in connection with the issuance of Additional Tier 1 Capital (AT1) of USD 500 million to optimise its capital structure.

The issuance is in the form of a debt instrument with automatic conversion into Class A shares if the Common Equity Tier 1 capital ratio of the bank falls below a certain level. The instruments will be listed on Euronext Dublin.

Vinge’s team consisted of Albert Wållgren, David Andersson and Arvid Weimers.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

 Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

 Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025